Introduction {#s0005}
============

*Phellinus gilvus* (Schwein.) Pat, a species of 'Sanghuang', belongs to the family Hymenochaetaceae in Basidomycota. Sanghuang (*Phellinus* spp*.*) have been used as a Chinese traditional medicine for over 2000 years to treat various diseases such as stomachache, inflammation and tumors. Recent investigations demonstrated that *Phellinus* spp*.* have multifunctional bioactivities, including anti-carcinogenesis, anti-inflammatory, anti-oxidative, anti-fungal and immunomodulatory activities, as well as anti-diabetic, hepatoprotective and neuroprotective effects [@b0005]. Phytochemical studies showed that *Phellinus* spp*.* are rich in phenylpropanoids and triterpenoids [@b0010]. But the main active components of *P. gilvus* are still largely unknown.

Sanghuang includes several species of *Phellinus* spp., which have similar phenotype, but the bioactivities of different origins were distinct. Due to the similar phenotype and limited genomic information, the accurate identification and classification of Sanghuang is difficult [@b0015]. The rapid development of next generation sequencing techniques makes it possible to further explore the fungi at the molecular level. Up to now, many genomes of fungi have been published in the Ensembl fungus database (<http://fungi.ensembl.org/index.html>). However, the genome information *P. gilvus* had not been reported. Here we sequenced the whole-genome of *P. gilvus* strain S12, which was a wild strain gathered from mulberry. A 41.11-Mb genome sequence was obtained, a total of 9982 gene models were annotated, and high-throughput chromosome conformation capture (Hi-C) data suggested that the majority of contigs could map onto 11 pseudochromosomes. High resolution electrospray ionization mass spectroscopy (HE-ESI-MS) and methyl thiazolyl tetrazolium (MTT) assays identified phenylpropanoids as the key components for the anti-carcinogenesis effect of *P. gilvus*, and their biosynthesis pathways were deduced based on genomic, transcriptomic data and molecular docking analysis.

Materials and methods {#s0010}
=====================

Fungal isolation and DNA preparation {#s0015}
------------------------------------

*P. gilvus* strain S12 was isolated from the fruiting body grown in a mulberry tree in Zhejiang province of China ([Fig. 1](#f0005){ref-type="fig"}A), which was identified as *P. gilvus* by Institute of Microbiology, Chinese Academy of Sciences (Beijing, China) based on culture characteristics, microscopic characteristics and rRNA gene sequence analysis. Briefly, it was based on the growth speed, color and morphology of vegetative mycelia, and the gene sequence of rRNA. The rRNA sequence of S12 have been submitted to NCBI (Accession No. MT275660). *P. gilvus* strain S12 has been deposited in our laboratory (Accession No. 2010S12). A patch of the fruiting body was inoculated into potato dextrose agar (PDA) medium at 28 °C ([Fig. 1](#f0005){ref-type="fig"}B). The grown mycelia were inoculated into potato dextrose broth (PDB) medium. Mycelium pellets 10 mm in diameter ([Fig. 1](#f0005){ref-type="fig"}C) were removed from media for extraction of genomic DNA. Genomic-tip kit (QIAGEN, Germany) was used for DNA extraction. Briefly, 1 mL of buffer B1 were add to the 20 mg mycelium pellets frozen in liquid nitrogen, and mix well with vortex. 2 μL RNaseA, 40 μL lysozyme and 45 μL Protesae K were added and reverse blending, 0.35 mL buffer B2 was added after incubation 60 min at 37 °C. And centrifugation at 12,000 rpm for 5 min after incubation 60 min at 50 °C. The supernatant were added to tips for DNA purification according to the handbook. The purified DNA were used for library construction.Fig. 1The separation and cultivation of *P. gilvus*. (A) Fruiting body grown on the mulberry tree; (B) Mycelia to colony; (C) Proliferating mycelium pellets in PDA liquid medium; (D) Artificial media used to culture of *P. gilvus*.

Genome size and heterozygosity estimation {#s0020}
-----------------------------------------

The 350-bp library was constructed according to Illumina's standard protocol and 2100 Bioanalyzer (Agilent, USA) was used for quantifying. The 350-bp library was subjected to paired-ended 150-bp sequencing by Illumina NovaSeq 6000 (CA, USA). The genome size of *P. gilvus* was estimated by the *k*-mer method [@b0020]. Quality-filtered reads were subjected to 17-mer frequency distribution analysis using the Jellyfish program. The genome size was estimated using the following formula: Genome size = *k*-mer number/average *k*-mer depth. The average *k*-mer depth is the *k*-mer depth corresponding to the main peak. The sequence where the *k*-mer depth appears at half of the corresponding depth of the main peak is a heterozygous sequence, and the sequences where the *k*-mer depth is more than twice the corresponding depths of the main peak are repetitive sequences.

Genome sequencing and assembly {#s0025}
------------------------------

*P. gilvus* strain S12 genome was sequenced by Single Molecule Real-Time (SMRT) method [@b0025]. DNA libraries with 20-kb inserts were constructed. The 20-kb library was constructed according to PacBio's standard methods and 2100 Bioanalyzer was used for quantifying. The sequencing data (filtered reads: 13.99-Gb, sequencing depth: 340.28×) was assembled by CANU (version 1.5) with default parameters [@b0030]. Quiver software is then used to polish the assembled genome [@b0025]. Finally, Illumina reads above were used for error correction and gap filling with Pilon [@b0035]. The integrity of the fungal genome assembly were evaluated by Benchmarking Universal Single-Copy Orthologs (BUSCO, version 2.0) [@b0040].

Hi-C assembly {#s0030}
-------------

To anchor scaffolds onto the chromosome, we conducted Hi-C auxiliary assembly. Sample preparation was according to Belton *et al* and Liu *et al* [@b0045], [@b0050]. Fresh mycelium pellets 10 mm in diameter ([Fig. 1](#f0005){ref-type="fig"}C) were removed from media for nuclei isolation. The purified nuclei were digested by *Hind* III and then were incubated with biotin-14-dCTP. The ligated DNA was cut into 300--700-bp fragments, and then was purified by biotin-streptavidin-mediated pull down as Hi-C library. Finally, we obtained sequencing data (5.68-Gb, 138.17×) via the NovaSeq 6000 platform (Illumina, CA, USA). The valid interaction pairs were acquired using Bowtie2 in HiC-Pro version 2.9.0 [@b0055]. BWA (version 0.7.15) [@b0060] was used to map the Hi-C short reads obtained from the Illumina HiSeq platform against the draft genome. The comparison mode was "aln" and the other parameters were set to the defaults. Division, sorting and orientation of the genome sequences were evaluated by LACHESIS, with parameters CLUSTER_MIN_RE_SITES = 41, CLUSTER_MAX\_ LINK_DENSITY = 1, CLUSTER_NONINFORMATIVE_RATIO = 5, ORDER_MIN \_N_RES_IN_TRUN = 10 and ORDER_MIN_N\_RES_IN_SHREDS = 10, Keep the defaults for all the other parameters [@b0065], [@b0070]. We used the Hi-C interacted signals to correct assembling errors. The genome assembled to the chromosome was cut into 20-Kb of one bin, the number of Hi-C mapped read pairs between any two bin was the signal intensity of the interaction. The heatmap was drawn according to the signal intensity of any two bins' interaction. The intensity signal was measured by the number of mapped read pairs between the two bins.

Genetic component analysis {#s0035}
--------------------------

Tandem repeat sequences were identified using LTR_FINDER version 1.05 [@b0075], MITE-Hunter [@b0080], RepeatScout version 1.0.5 [@b0085] and PILER-DF version 2.4 [@b0090]. PASTE Classifier [@b0095] was used to classify the database, which was then combined with the database of Repbase as the final repeat sequence database [@b0100]. RepeatMasker version 4.0.6 software was used to predict the repeat sequence of the fungus based on the established repeat sequence database [@b0105]. The software tRNAscan-SE was used to predict the tRNA in the genome [@b0110], and the software Infernal version 1.1 was used to predict the rRNA in the genome [@b0115] and other ncRNAs based on the Rfam database [@b0120]. The predicted protein sequences were compared with the protein sequences in the swiss-prot database [@b0125], and the homologous gene sequences (possible genes) were searched in the genome by using the software GenBlastA [@b0130], and then the immature termination codon and code shift mutations in the gene sequences were searched by using the software GeneWise to obtain the pseudogenes [@b0135].

Genome annotations {#s0040}
------------------

The prediction of gene structure was mainly based on *ab initio* prediction and homologous protein prediction. Genscan, Augustus (version 2.4), GlimmerHMM (version 3.0.4), GeneID (version 1.4) and SNAP (version 2006-07-28) were used for ab initio prediction [@b0140], [@b0145], [@b0150]. GeMoMa (version 1.3.1) was used for prediction based on homologous proteins [@b0155]. Finally, EVidenceModeler (version 1.1.1) was used [@b0160]. The predicted gene sequences were annotated functionally by COG, KEGG, swiss-prot, TrEMBL and Nr databases [@b0125], [@b0165], [@b0170], [@b0175]. Based on Nr database, GO databases were annotated by Blast2GO [@b0180]. Hmmer software (version 3.2.1) was used for function annotation based on Pfam database [@b0185], [@b0190]. The predicted gene protein sequences were annotated by functional databases antiSMASH (version 5.0, <https://antismash.secondarymetabolites.org/>) with default parameter [@b0195].

Homologous gene analysis and phylogenetic tree construction {#s0045}
-----------------------------------------------------------

OrthoVenn2 (<https://orthovenn2.bioinfotoolkits.net/>) was used to compare and annotate the orthologous gene clusters among the four fungi in Hymenochaetaceae [@b0200]. The parameter settings of E-value = 1e−5, Inflation value = 1.5. OrthoMCL (version 2.0.9) was used to cluster the protein sequences [@b0205]. All-vs-all blastp reciprocal best hit was used for all proteins, and E-value = 1e−5. According to the results of gene family clustering, single copy orthologous genes were extracted, and multiple sequence alignment of single copy homologous proteins were conducted by MUSCLE software. Finally, phylogenetic tree is constructed by PhyML, with the JTT model and 100 bootstrap replicates [@b0210]. We then used MCMCTREE to estimate the divergence times [@b0215], and the parameter were as follows: clock = 2, model = 3, BDparas = 110, kappa gamma = 62, alpha gamma = 11, rgene gamma = 11 and sigma2 gamma = 14.5. The sequence information of these fungi were acquired from Ensembl fungus database, the accession numbers were GCA_002287475 (*Phellinus noxius*), GCA_001020605 (*Schizopora paradoxa*), GCA_000271605 (*Fomitiporia mediterranea*), GCA_002760635 (*Ganoderma sinense*), GCA_000344655 (*Fomitopsis pinicola*), GCA_000143185 (*Schizophyllum commune*), GCA_002003045 (*Lentinula edodes*) and GCA_001632375 (*Exidia_glandulosa*).

Transcriptome sequencing {#s0050}
------------------------

The mycelia ([Fig. 1](#f0005){ref-type="fig"}C) and fruiting body ([Fig. 1](#f0005){ref-type="fig"}D) were prepared for the transcriptome sequencing. There were three biological replicates for each sample. TRIzol reagent (Invitrogen, USA) were used for isolation of Total RNA. Agilent 2100 Bioanalyzer, a NanoDrop (NanoDrop, USA), and a Qubit 2.0 (Invitrogen, USA) were used to assess the integrity, purity and concentration of total RNA. The libraries' construction and RNA-Seq were conducted by the Biomarker Biotechnology Corporation (Beijing, China). The HISTAT2 was used to map clean reads (\>100-bp) to the genome with the default parameters [@b0220]. The mapped reads were assembled to transcripts via StringTie [@b0225]. The transcript or gene expression levels were measured by FPKM (Fragments Per Kilobase of transcript per Million fragments mapped) [@b0230]. The Fold Change (FC) ≥ 2 and False Discovery Rate (FDR) less than 0.01 were identified as differentially expressed genes (DEGs).

Preparation of extracts of *P. gilvus* mycelia and fruiting body {#s0055}
----------------------------------------------------------------

The dried fruiting body and mycelia powder was extracted with boiling water for 2 h. The aqueous extracts were concentrated by rotary evaporator and then were mixed with three volumes of ethanol. The supernatant was collected after centrifugation. The supernatant was lyophilized to obtain extracts powders.

High performance liquid chromatography (HPLC) and HE-ESI-MS analysis {#s0060}
--------------------------------------------------------------------

The extracts (1 g) of power were desalted through a C18 column (H~2~O, methanol), and then dissolved in 75% methanol. HPLC was performed on an Agilent 1260 HPLC system. Chromatographic separation was performed on an Exsil Plus EPS C18 (5 μM, 4.6 × 250 mm). The sample size was 10 µL. The mobile phase A was waterwith 0.3% formic acid and mobile phase B was acetonitrile with 0.3% formic acid. A mobile phase gradient was used with the percentage of B in A varying as follows: initial concentration (0 min), 5% B; 15 min, 10% B; 20 min, 20% B; 35 min, 30% B; 60 min, 50% B. The flow rate was 1 mL/min, and the column temperature was maintained at 30 °C. The eluted fractions of each peaks were collected and analyzed by HE-ESI-MS (an Agilent G6224A TOF spectrometer). The TOF mass spectrometer with an ESI interface (Agilent, USA) were used for HE-ESI-MS experiments. The positive ESI conditions were as follows: gas temperature = 350 °C, drying gas = 9 L/min, nebulizer = 40 psig, capillary = 3500.

MTT assays {#s0065}
----------

The inhibitory effects of extracts on the human hepatocellular carcinoma (HepG2) cells were measured by the analysis of live cells number determined with a MTT-based colorimetric assay according to Li *et al* [@b0235]. Briefly, the cells (1 × 10^5^ cells/well) were added to a 96-well plate, with different final concentration of extracts or dimethyl sulfoxide (DMSO, negative control). After cultivation for 48 h, the percentage of living cells was determined by reading absorbance at 570 nm with a Benchmark microplate reader (Bio-Rad, USA). The inhibition rate (%) = 1 − (mean absorbency in test wells)/(mean absorbency in control wells) × 100%.

Molecular docking {#s0070}
-----------------

The possible interactions between each isolated compound and the corresponding enzyme binding sites were analyzed by Molecular Operating Environment (MOE) software package (Chemical Computing Group, Canada). A molecular modeling study was performed using the docking program named Induced-Fit, a refinement method in software MOE. To eliminate any bond length and bond angle biases, the ligands were subjected to an "energy minimize" prior to docking. The binding affinities (S-values) in MOE were used to evaluate the interactions between proteins and ligands. The scores (binding affinities) were obtained based on the virtual calculation of various interactions of the ligands with the targeted receptors [@b0240].

Results {#s0075}
=======

Genome size and heterozygosity estimation {#s0080}
-----------------------------------------

*P. gilvus* strain S12 was used for genome sequencing. 2.69-Gb high-quality data (\~80×) were obtained. Based on the *k*-mer genome survey analysis, *P. gilvus* was estimated to have a genome size of 33.36-Mb ([Table 1](#t0005){ref-type="table"}). *k*-mer analysis with a length of 17 (17-mers) indicated the genome had a heterozygosity of 0.52% and a repetitive sequence content of \~16.63% ([Fig. 2](#f0010){ref-type="fig"}A), which indicated that *P. gilvus* strain S12 was a binuclear fungus.Table 1Statistics for the *P. gilvus* Genome.FeaturesNumberLengthPercentage (%)Estimated genome size33.36-MbAssembled contig sequences7341.11-MbContig N502.37-MbContig N90132.69-KbContig Max4.15-MbTotal read pairs (Hi-C)19,013,106Mapped reads (Hi-C)30,520,07580.26Unique mapped read pairs(Hi-C)9,838,03551.74Assembled scaffold sequences7941.11-MbScaffold N502.42-MbScaffold N90119.48-KbScaffold Max6.61-MbAnchored scaffolds6735.09-Mb85.36%Gap length2.30-KbGC content (%)47.89Chromosome11Fig. 2General features of the *P. gilvus* genome sequencing. (A) The *k*-mer distribution. (B) Subreads length distribution. The abscissa represents the length of the subreads (bp); the left ordinate represents the number of subreads, which corresponds to the green bar graph; the right ordinate represents the total number of bases (Mb) of subreads larger than the corresponding length; and the red dashed line represents the length of the N50 of the subreads.

Genome sequencing, assembly and annotation {#s0085}
------------------------------------------

For accurate assembly information of the reference genome, the *P. gilvus* strain S12 genome was sequenced using a *de novo* assembly strategy combining PacBio single-molecule long reads with Hi-C auxiliary assembly. A 41.11-Mb genome sequence was obtained by assembling 982,223 PacBio reads (\~340×), which is larger than the estimated genome size of 33.36-Mb obtained from the *k*-mer analysis ([Fig. 2](#f0010){ref-type="fig"}B). The draft genome assembly consisted of 73 contigs with a contig N50 of \~2.37-Mb ([Table 1](#t0005){ref-type="table"}). 273 complete conservative core genes (94.14%) were found in fungal BUSCO. In order to improve the draft genome from genome-assembly level to chromosome level, we used LACHESIS to assemble contigs onto 11 pseudochromosomes based on 5.68-Gb, (\~138×) of Hi-C data ([Fig. 3](#f0015){ref-type="fig"}A). The alignment efficiency between mapped reads and the assembled genome is 80.26%, among which the ratio of unique mapped read pairs is 51.74%. A heatmap created with Hi-C data suggested that all bins could be clearly divided into the 11 pseudochromosomes, which was consistent to the LACHESIS assembly. Within each group, the interaction intensity at diagonal position is higher than that at non-diagonal position were observed, which indicated that the interaction intensity between adjacent sequences was high (Supporting Information Fig. S1). In turn, parts of the contigs were interrupted because of lacking interaction signals in heatmap. As a result, the genome assembly by Hi-C consisted of 79 scaffolds with a scaffold N50 of \~2.42-Mb, the gap was 2.3-Kb. A total of 35.09-Mb (85.36%) sequence was anchored to the 11 pseudochromosomes. We finally generated a 41.11-Mb of *P. gilvus* genome, with a contig N50 of \~2.37-Mb and scaffold N50 of \~2.42-Mb ([Table 1](#t0005){ref-type="table"}).Fig. 3Genomic characterization and comparative genomics of *P. gilvus*. (A) The outer circle is the chromosome marked with the number, the scale value unit is Mb; The second circle (yellow) is gene density, which counts the number of genes per 10-kb of genome length. The third circle (blue) is GC content, and the GC percentage per 1-kb length of genome is calculated, the minimum scale value is 20%, and the maximum scale value is 80%. The innermost line is the corresponding relation of repeated sequences. The gray line is the repeated sequence of 5--10-kb, and the red line is the repeated sequence of more than 10-kb. (B) The Venn diagram indicates the numbers of genes shared among the four Hymenochaetales; (C) Phylogenetic tree of *P. gilvus* with 8 other fungi species genome covering 4 fungi orders (Hymenochaetales, Polyporales, Agaricales, and Auricularia) in Agaricus. The histogram is the statistics of gene types.

A total of 9982 gene models were predicted (Supporting Information Table S1), with an average sequence length of 2367.12-bp. On average, each predicted gene contains 7.31 exons and 6.31 introns (Supporting Information Table S2). 9521 genes could be annotated by functional databases (GO, KEGG, COG, Pfam, Swiss-prot, TrEMBL and Nr) (Supporting Information Table S3). According to GO database, annotated genes were mainly distributed in 4 functional entries, "Catalytic activity", "Binding", "Metabolic process" and "Cellular process" (Supporting Information Fig. S2A). By NCBI COG mapping, 6056 proteins were assigned to COG categories (Supporting Information Fig. S2B). "General functional prediction only" had the highest number of genes (1028), which were not unambiguously assigned to a particular group. This was followed by "posttranslational modification, protein turnover, chaperones" (542) and "signal transduction mechanisms" (488) as the most gene-rich classes in the COG groupings. 288 genes involved in "Secondary metabolites biosynthesis, transport and catabolism" were identified. These findings are consistent with the results of *P. gilvus* rich in secondary metabolites.

In total, 8.57-Mb (20.85%) of repetitive sequences were identified, the majority of the repeats are Class 1 (18.21% of the genome; Supporting Information Table S4). 8230 (82.45%) genes were anchored to the 11 pseudochromosomes. In addition, 149 noncoding RNAs and 525 pseudogenes were predicted.

Comparative genomic and phylogenomic analyses {#s0090}
---------------------------------------------

The OrthoVenn2 was used to identify orthologous genes among *P. gilvus* and 3 other fungi species in Hymenochaetales, and a total of 5099 orthologous genes and 268 unique genes were identified ([Fig. 3](#f0015){ref-type="fig"}B). Among the 268 unique genes, 214 genes could be functionally annotated by GO database (Supporting Information Fig. S3). According to the annotation, these genes mainly distributed in biological process (25), metabolic process (18) and cellular metabolic process (13). The molecular function mainly involved in oxidoreductase activity (11), binding (6) and transferase activity (6). The most genes (7) of GO enrichment is involved in oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, which were involved in secondary metabolites biosynthesis. All these data suggested *P. gilvus* might have better medicinal activity.

To investigate the evolutionary position of *P. gilvus* in Agaricus, we compared and identified orthologous genes among *P. gilvus* and 8 other fungi species covering 4 fungi orders (Hymenochaetales, Polyporales, Agaricales and Auricularia) in Agaricus by OrthoMCL. A total of 1538 single-copy orthologous genes were identified. We inferred a phylogeny and divergence estimate using 13,842 orthologous genes. The phylogenetic analysis showed that *P. gilvus* was more closely related to *Fomitiporia mediterranea*, and the estimated divergence time of *P. gilvus* and *F*. *mediterranea* was 84 millions of years ago (Mya). *P. gilvus* diverged from Polyporales and Agaricales was about 223 Mya ([Fig. 3](#f0015){ref-type="fig"}C).

Phenylpropanoids may be the key anti-carcinogenesis components in *P. gilvus* {#s0095}
-----------------------------------------------------------------------------

In order to further investigate the medicinal values of *P. gilvus*, we carried out HepG2 cells inhibitory assay among mycelia and fruiting body. The inhibitory effects of extracts were tested on HepG2 cells under dosages of 400 and 800 μg/mL. As shown in [Fig. 4](#f0020){ref-type="fig"}A, *P. gilvus* fruiting body exhibited a more potent inhibition on HepG2 cells growth than mycelia. At the doses of 400 and 800 μg/mL, the inhibition rate of *P. gilvus* fruiting body extracts were 34.14% and 77.38% on HepG2 cells, compared to 29.14% and 41.37% of mycelia, respectively.Fig. 4Analysis of medicinal values of *P. gilvus*. (A) The inhibitory efficiency of extracts on the proliferation of HepG2 hepatocarcinoma cells. (B) HPLC analyses of different medical fungi extracts. The indicated compounds are as follows: (I) *P. gilvus* mycelia, (**1**) (10E, 12Z, 15Z)-9-hydroxy-10, 12, 15-octadecatrienoic, (**2**) 9-deoxy-11β-hydroxyprostratin, (**3**) unknown compound and (**4**) unknown compound; (II) *P. gilvus* fruiting body, (**1**) β-Adenosine, (**2**) 5,6-Dihydrouracil, (**3**) 3,4-Dihydroxybenzalacetone, (**4**) Hydroxycinnamic acid; (**5**) Phellibaumin D, (**6**) Interfungin B, (**7**) Phelligridimer A, (**8**) Gliotoxin and (**9**) Inoscavin A. (C) The inhibitory efficiency of five phenylpropanoids from *P. gilvus* on the proliferation of HepG2 hepatocarcinoma cells. (D) Morphology of HepG2 cells after treatment with different phenylpropanoids from *P. gilvus*. The dosage of P3, P5, P6 and P7 was 80 μg/mL, P9 was 20 μg/mL. Date are presented as the mean ± SE (n = 5).

To clarify the cause for the differential anti-carcinogenesis efficacies, the compounds were analyzed by HPLC and HE-ESI-MS. As shown in [Fig. 4](#f0020){ref-type="fig"}B, the main bioactive compounds of *P. gilvus* fruiting body were phenylpropanoids (3, 4-dihydroxybenzalacetone, hydroxycinnamic acid, phellibaumin D, interfungin B, phelligridimer A and inoscavin A), and *P. gilvus* mycelia possessed scarce secondary metabolites (Supporting Information Tables S5 and S6, Data S1).

To confirm the anti-carcinogenesis activity of phenylpropanoids in *P. gilvus* fruiting body, five phenylpropanoids compounds (3, 4-dihydroxybenzalacetone, phellibaumin D, interfungin B, phelligridimer A and inoscavin A) were isolated for MTT assays, some of which were unique in *Phellinus* spp. [@b0005]. As is shown in [Fig. 4](#f0020){ref-type="fig"}C and D, all five compounds exhibited adequate and dose-dependent anti-carcinogenesis activities *in vitro*. At the dose of 80 μg/ml, the inhibition rate of the five compounds were 47.33%, 55.06%, 44.50%, 24.68% and 82.27%, respectively. These data suggested that phenylpropanoids might be the key anti-carcinogenesis component in *P. gilvus* fruiting body.

Synthesis pathway of phenylpropanoids in *P. gilvus* {#s0100}
----------------------------------------------------

Some studies have found that secondary metabolic-related synthesis genes exist in clusters [@b0245], so we annotated the genome by AntiSMASH database, which allows the rapid identification secondary metabolite biosynthesis gene clusters in fungal genomes [@b0195], as the Table S7 shown, the gene clusters of *P. gilvus* were classified into terpene, NPRS-like and T1PKS, but there were no phenylpropanoids biosynthetic gene clusters were annotated.

In order to further explore the biosynthetic pathways of the active phenylpropanoids, RNA-Seq analysis of *P. gilvus* samples collected from mycelia ([Fig. 1](#f0005){ref-type="fig"}C) and fruiting bodies were performed ([Fig. 1](#f0005){ref-type="fig"}D). A total of 53.17-Gb clean data were obtained after mRNA sequencing for 6 samples with at least 8.35-Gb clean data for each sample. Percentage of mapped clean reads compared to all clean reads varied from 89.29% to 96.46% (Supporting Information Table S8). A total of 3435 DEGs (1741 enriched in fruiting body and 1694 enriched in mycelia) were identified. By NCBI COG mapping, of the 1741 fruiting body-enriched genes, "General functional prediction only" (125), "Carbohydrate transport and metabolism" (106) and "Secondary metabolites biosynthesis, transport and catabolism" (85) are the most gene-rich classes (Supporting Information Fig. S4).

HPLC and HE-ESI-MS results showed that *P. gilvus* fruiting body contained all the five phenylpropanoids while the mycelia contained none of them ([Fig. 4](#f0020){ref-type="fig"}B, Supporting Information Tables S5 and S6, Data S1). *PAL*, cinnamate-4-hydroxylase (*C4H*), *p*-coumarate 3-hydroxylase (*C3H*) and *4CL* are four key enzyme genes, which are responsible for caffeoyl-CoA from phenylalanine. Caffeoyl-CoA are important precursor for various phenylpropanoids biosynthesis [@b0250]. Therefore we examined the expression levels of genes that are involved in phenylpropanoids biosynthesis. Among the phenylpropanoids-biosynthetic genes, 4 were enriched in the fruiting body (*PAL*, 3/3; *4CL*, 1/3). There no rigorous cinnamate-4-hydroxylase (*C4H*), *p*-coumarate 3-hydroxylase (*C3H*) genes could be annotated by KEGG. Because both *C4H* and *C3H* belong to cytochrome P450 monooxygenase superfamily [@b0255], we identified several cytochrome P450 monooxygenase genes (*P450s*, 11/33) that may be involved in phenylpropanoids biosynthesis, which were enriched in the fruiting body (Supporting Information Table S10). These results suggested that the above genes might be involved in the synthesis of phenylpropanoids.

According to Lee and Yun, Hispidin, hispolon and 3, 4-dihydroxybenzalacetone were derived from caffeoyl-CoA, which were important intermediate products for biosynthesis of phenylpropanoids. Caffeoyl-CoA was biosynthesized via cinnamic acid, *p*-coumaric acid pathway [@b0250]. Hispidin might be biosynthesized via enlongation and self-cyclization of caffeoyl-CoA, with cooperation of polyketide synthase (*PKS*) and palmitoyl protein thioesterase (*PPT*) genes. And hispolon might be biosynthesized via enlongation, decarboxylation and dehydrogenation of caffeoyl-CoA, with cooperation of *PKS*, *PPT* and decarboxylase genes. Under the action of dehydrogenase, hispolon turns to its quinone structure. Then, additional reaction happened between these two compounds, later intramolecular addition reaction happened to get a more stable compound inoscavin A [@b0250], [@b0260]. The putative genes involved in inoscavin A biosynthesis, that are *PAL* and *4CL*, could be annotated in *P. gilvus* genome (Supporting Information Table S9), and four intermediates were found in our study and other researches [@b0005], [@b0250]. Cytochrome P450 monooxygenase genes, *PKS*, *PPT*, decarboxylase and dehydrogenase genes, which might be involved in biosynthesis of inoscavin A, were also enriched in the fruiting body (Supporting Information Table S9). Based on the data above, we deduced the biosynthetic pathways of inoscavin A ([Scheme 1](#f0030){ref-type="fig"}). In the same way, we inferred that 3, 4-dihydroxybenzalacetone might be synthesized from caffeoyl-CoA by elongation and decarboxylation (Supporting Information Scheme S1), phellibaumin D was synthesized by the coupling of hispidin and oxidation product of caffeic acid (Supporting Information Scheme S2), interfungin B was synthesized by the coupling of hispidin and oxidation product of 3, 4-dihydroxybenzalacetone (Supporting Information Scheme S3).Scheme 1Key steps in inoscavin A biosynthesis. Catalyzed by the enzymes phenylalanine ammonia-lyase (PAL), cytochrome P450 monooxygenase (P450), 4-coumarate-CoA ligase (4CL), polyketide synthase (PKS), palmitoyl protein thioesterase (PPT) and some presumed enzymes. Several representative intermediates are shown.

In order to narrow the scope of candidate genes in the synthesis pathway, the possible interactions between each isolated compound and the corresponding enzyme binding sites were analyzed by molecular docking. Since the major sequence similarities of the *P. gilvus*-derived enzymes to the proteins with known structures are less than 20%, we could not use homology modeling methods for docking analysis. So we had to use the most similar proteins from protein data bank (PDB) database to conduct molecular docking analysis, thus providing clues of the potential binding of the compounds to their catalytic enzymes. The S-values were obtained based on the virtual calculation of the interaction of ligands with the targeted proteins. Higher absolute value of S score indicates stronger binding between compound and protein. The \|S score\| \> 5 indicates adequate binding affinity while \|S score\| \> 6 suggests a strong interaction [@b0240]. As the [Table 2](#t0010){ref-type="table"} shown, the optimal candidate enzymes, such as P450, PKS, PPT, decarboxylase and dehydrogenase, were filtrated with S-values −5.29, −5.01, −8.47, −10.91, −6.75 and −6.61 respectively ([Table 2](#t0010){ref-type="table"}, [Fig. 5](#f0025){ref-type="fig"} and Supporting Information Data S2).Table 2The optimal candidate genes obtained by molecular docking analysis in Inoscavin A biosynthesis.Gene IDGene namePDB IDCompound IDS scoreEVM0000919PAL1W271−4.63EVM0001849P4502Q9F2−5.29EVM0002405P4502Q9F2−5.29EVM0003813P4502Q9F2−5.29EVM0004734P4502Q9F2−5.29EVM0006460P4502Q9F2−5.29EVM0007121P4502Q9F2−5.29EVM0009092P4502Q9F2−5.29EVM0009176P4502Q9F2−5.29EVM0001849P4502Q9F3−5.01EVM0002405P4502Q9F3−5.01EVM0003813P4502Q9F3−5.01EVM0004734P4502Q9F3−5.01EVM0006460P4502Q9F3−5.01EVM0007121P4502Q9F3−5.01EVM0009092P4502Q9F3−5.01EVM0009176P4502Q9F3−5.01EVM00066384CL2D1S4−6.2EVM0007106PKS2QO35−8.47EVM0004239PPT1C8U6/7−10.91EVM0001166Decarboxylase2P1F9−6.75EVM0002689Dehydrogenase4QI310−6.61EVM0002854Dehydrogenase4QI310−6.61Fig. 5Molecular docking analysis of Inoscavin A biosynthesis related genes. (A) Molecular docking analysis of polyketide synthase (PKS, EVM0007106) and its corresponding substrate. (B) Molecular docking analysis of palmitoyl protein thioesterase (PPT, EVM0004239) and its corresponding substrate.

Discussion {#s0105}
==========

Sanghuang are traditional medicinal fungi, mainly including *P. igniarius*, *P. baumii*, *P. linteus* and so on [@b0015]. Here we found a wild species parasitic on mulberry, the fungus was identified as *P. gilvus* by Institute of Microbiology, Chinese Academy of Sciences (Beijing, China) based on culture characteristics, microscopic characteristics and rRNA gene sequence analysis. We estimated the genome size by *k*-mer analysis and found that the estimated genome size was 33.36-Mb and it was a binuclear fungus ([Fig. 2](#f0010){ref-type="fig"}A). Because of the high heterozygosity, the short reads produced by Illumina platform might be assembled incorrectly. In detail, binuclear fungus may contain two sets of highly homologous genomes, the short reads produced by Illumina platform might be assembled the two homologous genomes into one genomes by mistake, resulting a smaller and incorrect genome size was estimated. The SMRT technology conducted by PacBio platform can deliver more highly accurate long reads [@b0025]. Therefore we conducted genome sequencing combining PacBio long-reads sequencing with Hi-C auxiliary assembly. The sequencing data generated by PacBio platform showed the draft genome size was 41.11-Mb, consisting of 73 contigs with a contig N50 of \~2.37-Mb ([Fig. 2](#f0010){ref-type="fig"}B, [Table 1](#t0005){ref-type="table"}). Genome assembly *de novo* from PacBio's reads also might exist a few incorrect assembly because of the high heterozygosity. Hi-C data is a rich source of long-range information for assigning, ordering and orienting draft-genome sequences to chromosomes, and it can also interrupt incorrect assembly according to the interaction intensity [@b0070]. It can perfectly cooperate with PacBio to complete high-quality genome assembly. As a result, 73 contigs were re-assembled into 79 scaffolds. The scaffold N50 was \~2.42-Mb and the gap length was 2.30-Kb. Hi-C auxiliary assembly suggested that *P. gilvus* had 11 pseudochromosomes. A total of 35.09-Mb (85.36%) sequence was anchored to the 11 pseudochromosomes ([Table 1](#t0005){ref-type="table"}). 273 complete conservative core genes (94.14%) were found in fungal BUSCO. All these proved that PacBio platform with Hi-C auxiliary assembly helped us to obtain a more high-quality genome data. It is also the first report of *P. gilvus* genome.

Comparative genomics analysis in Hymenochaetales showed *P. gilvus* had 268 unique genes ([Fig. 3](#f0015){ref-type="fig"}B). The richest genes were related to oxidoreductase activity, which might involve in secondary metabolites biosynthesis (Supporting Information Fig. S3). This might be the reason why *C4H* and *C3H* genes, which had oxidoreductase activity, could not be annotated in *P. gilvus* genome. These founding implied that *P. gilvus* had unique medicinal values.

Phenylpropanoids are the most representative and predominant type of bioactive compounds in *Phellinus* spp. [@b0005]. Chao *et al* [@b0265] found that 3, 4-dihydroxybenzalacetone could suppress human non-small cell lung carcinoma cells metastasis. Hispidin exerted antitumor effects against pancreatic cancer cells, gastric cancer cells, HepG2 and human erythroleukemia cells [@b0270], [@b0275], [@b0280]. Hispolon could induce apoptosis in melanoma cells and inhibit the growth of human breast cancer cells [@b0285], [@b0290]. Phellifuropyranone A, meshimakobnol A and meshimakobnol B showed anti-proliferative activity against mouse melanoma cells and human lung cancer cells *in vitro* [@b0295]. Zhang *et al* [@b0300] found that 3, 4-dihydroxybenzalacetone and inoscavin A from *P. baumii* showed proliferation inhibition activity on tumor cells. However, there is no report on anti-carcinogenesis activity of the other phenylpropanoids compounds in *Phellinus* spp. Here we isolated five major phenylpropanoids (3, 4-dihydroxybenzalacetone, phellibaumin D, interfungin B, phelligridimer A and inoscavin A) in *P. gilvus* and tested their anti-carcinogenesis activity. Four compounds exhibited higher anti-carcinogenesis activities *in vitro*. Some of them were newly high activity anti-carcinogenesis compounds in *P. gilvus*.

It has not been reported for the synthetic pathways of phenylpropanoids in *P. gilvus* so far. Nambudiri *et al* [@b0305] proposed that caffeic acid was the precursors of hispidin, which is an important intermediate in the synthesis of other phenylpropanoids. Lee and Yun [@b0250] reviewed that biosynthesis of hispidin was the incorporation of two acetate units and L-phenylalanine in *Polyporus schweinizii*. Tracer studies showed incorporation of D, L-phenylalanine, D, L-tyrosine, cinnamate, *p*-coumarate and caffeate into the styryl unit, and efficient incorporation of acetate and malonate into the pyrone ring [@b0310]. According to the results of the integrated metabolome and proteome study in *P. gilvus*, the increase of polyphenol content was caused by upregulation of the phenylpropanoid biosynthesis, such as PAL, C4H and 4CL [@b0280]. *PAL*, tyrosine ammonia-lyase *(TAL)*, *C4H*, and *C3H* are key genes for caffeic acid biosynthesis. *PAL*, could be identified in genome of *P. gilvus*, however we could not identify *TAL* according to the gene annotation of *P. gilvus*, suggested that the phenylpropanoids were phenylalanine-derived in *P. gilvus* (Supporting Information Table S9). Hispidin and hispolon derived from caffeyl-CoA and were the result of elongation by malonyl-CoA [@b0250], [@b0315]. The PKS and PPT are key enzymes for the elongation (Supporting Information Table S9). Inoscavin A was considered to be synthesized by the coupling of hispidin and quinone structure of hispolon [@b0250], [@b0320].

Phenylpropanoids biosynthetic gene clusters could not be identified according to antiSMASH analysis, excepting several NPRS and T1PKS clusters, which might involve in elongation of caffeyl-CoA (Supporting Information Table S7). So we conducted RNA-seq for further exploring the biosynthetic pathways of the bioactive phenylpropanoids. DEGs analysis showed that plenty of genes including *PAL*, *4CL*, *P450*, *PKS*, *PPT*, decarboxylase and dehydrogenase genes probably involved in the bioactive phenylpropanoids biosynthesis were enriched (Supporting Information Table S9), which were synergetically changed with the production of these phenylpropanoids. Based on the above information, we speculated on the biosynthesis pathway of inoscavin A in *P. gilvus* ([Scheme 1](#f0030){ref-type="fig"}). In the same way, we also deduced the biosynthetic pathways of the other three high bioactive phenylpropanoids (3, 4-dihydroxybenzalacetone, phellibaumin D and interfungin B; Supporting Information Schemes S1--S3).

In order to screening for optimal candidate genes in the phenylpropanoids' synthesis pathway, we conducted molecular docking analysis. The S-values of PKS, PPT, decarboxylase and dehydrogenase enzymes, were −8.47, −10.91, −6.75 and −6.61 respectively ([Table 2](#t0010){ref-type="table"}, [Fig. 5](#f0025){ref-type="fig"} and Supporting Information Data S2), which suggested a strong interaction between each isolated compound and the corresponding enzyme. These data proved that the synthetic pathways of these phenylpropanoids were reliable, and these will provide important resources for the exploration of the synthetic pathway of phenylpropanoids in *P. gilvus*.

Conclusions {#s0110}
===========

This paper reports a high quality whole-genome sequence of a new species of Sanghuang, *P. gilvus* strain S12, for the first time. We also confirmed that phenylpropanoids were the key anti-carcinogenesis components in *P. gilvus*. And four high bioactive phenylpropanoids' biosynthetic pathways were deduced. These data generated in this work will be a valuable resource for further genetic improvement and effective use of the *P. gilvus*. And it also provided theoretical bases for the development of new anti-carcinogenesis drugs and synthetic biology.
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